Product Name:

FGFA/FHFA (pan)


Product Number:

ab-nn246-1

Price:

Regular price
$105.00
Regular price
Sale price
$105.00

Download Product PDF

Target Full Name: Fibroblast growth factor 13

Target Alias: Acidic fibroblast growth factor; AFGF; Beta endothelial cell growth factor; Fibroblast growth factor homologous factor 2A; FGF13A; Beta-endothelial cell growth factor; ECGF; ECGFA; ECGFB; Endothelial Cell Growth Factor alpha; Endothelial Cell Growth Factor alpha; Endothelial Cell Growth Factor beta; FGF 1; FGF alpha; FGFA; Fibroblast Growth Factor 1 Acidic; Fibroblast growth factor 1; GLIO703; HBGF 1; HBGF1; Heparin binding growth factor 1; Heparin binding growth factor 1 precursor; Heparin-binding growth factor 1

Product Type Specific: Growth factor protein pan-specific antibody

Antibody Code: NN246-1

Antibody Target Type: Pan-specific

Protein UniProt: Q92913

Protein SigNET: FGFA/FHFA (pan)

Antibody Type: Monoclonal

Antibody Host Species: Mouse

Antibody Ig Isotype Clone: IgG2b

Antibody Immunogen Source: Synthetic peptide patterned after human FHF2A

Antibody Immunogen Sequence: AAAIASSLIRQKRQARE

Antibody Immunogen Description: Corresponds to amino acid residues A2-E18. 100% identical to rat, 94% identical to mouse. >80% identity with FGF12A/FHF1A, FGF14A/FHF4A and FGF11A/FHF3A.

Production Method: Protein G purified

Antibody Modification: Unconjugated. Contact KInexus if you are interest in having the antibody biotinylated or coupled with fluorescent dyes.

Antibody Concentration: 1 mg/ml

Storage Buffer: Phosphate buffered saline pH 7.4, 50% glycerol, 0.1% sodium azide

Storage Conditions: For long term storage, keep frozen at -40°C or lower. Stock solution can be kept at +4°C for more than 3 months. Avoid repeated freeze-thaw cycles.

Product Use: Western blotting | Immunohistochemistry | ICC/Immunofluorescence

Antibody Dilution Recommended: WB (1:1000); optimal dilutions for assays should be determined by the user.

Antibody Potency: In mouse brain lysates, this antibody detects a ~30 kDa protein by Western blotting.

Antibody Species Reactivity: Human | Rat | Mouse

Antibody Positive Control: 1 µg/ml of SMC-448 was sufficient for detection of FGFA/FHFA (pan) in 20 µg of rat brain lysate by colorimetric immunoblot analysis using Goat anti-mouse IgG:HRP as the secondary antibody.

Antibody Specificity: Very high

Antibody Cross Reactivity: This antibody detects the target protein in the following species due to conservation of amino acid sequence: Human | Rat | Mouse.

Scientific Background: FGF13 (Fibroblast growth factor 13, FHF2) is an intracellular protein primarily expressed in the nervous system and heart, crucial for microtubule stabilization, neuronal development, and regulation of voltage-gated sodium channels. Unlike typical FGFs, it is non-secreted, and functions in the cytoplasm. It binding to the C-terminus of voltage-gated sodium channels (NaV) to regulate their stability and function. FGF13 is a large gene, extending over approximately 200 kb in Xq26.3, and contains at least 7 exons. By cytogenetic, FISH, and database analysis, Gecz et al. (1999) localized the FGF13 gene within a 400-kb duplication interval on chromosome Xq26.3. FGF family members possess broad mitogenic and cell survival activities, and are involved in a variety of biological processes, including embryonic development, cell growth, morphogenesis, tissue repair, tumour growth, and invasion. FGF13 directly binds and polymerizes tubulins, essential for axon development and neuron migration, especially in the cortex and hippocampus. In the development of the nervous system, it plays a key role in neuronal polarization, leading process development, and the formation of inhibitory synapses. It is highly expressed in the developing and adult central and peripheral nervous systems. t is found in both the cytoplasm and nucleus, particularly concentrated in axonal growth cones. The FGF13 gene is located to a region associated with Borjeson-Forssman-Lehmann syndrome (BFLS), a syndromal X-linked mental retardation, which indicates that it may be a candidate gene for familial cases of the BFL syndrome. Two alternatively spliced transcripts encoding different isoforms (e.g., FGF13A, FGF13B) have been described for this gene. This description may include information annotated by UniProt and/or Google AI.